AHCL

DEVICE3 trials

Sponsors

Christchurch Clinical Studies Trust Ltd, Medtronic Diabetes, Hospital Universitario San Ignacio

Conditions

Surgery, DayType 1 DiabetesType 1 Diabetes (T1D)Type1diabetes

Unknown Phase

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Christchurch Clinical Studies Trust LtdType1diabetes

Start: 2019-05-20End: 2019-10-11Target: 60Updated: 2019-08-29

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes

CompletedNCT04235504

Medtronic DiabetesType 1 Diabetes

Start: 2020-07-13End: 2022-05-30Updated: 2023-03-27

Efficacy and Safety of the Minimed 780G® Advanced Hybrid Closed Loop System (AHCL) in Patients With Type 1 Diabetes Undergoing Surgery

CompletedNCT06947031

Hospital Universitario San IgnacioSurgery, Day, Type 1 Diabetes (T1D)

Start: 2023-08-01End: 2025-04-30Updated: 2025-09-23

Related Papers

A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes

Diabetes Technology & Therapeutics2023-10-0614 citations

Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes

Diabetes Obesity and Metabolism2023-08-0815 citations

999-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A United States Perspective

Diabetes2023-06-20

1009-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A Singapore Perspective

Diabetes2023-06-20

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.

2022-09-01114 citations

Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale

BMJ Open2022-02-016 citations